In a report published Friday, Cantor Fitzgerald analyst Jeremy Feffer upgraded the rating on Align Technology ALGN from Hold to Buy, and raised the price target from $42.00 to $60.00.
In the report, Cantor Fitzgerald noted, “We are upgrading ALGN from HOLD to BUY and raising our price target from $42 to $60 following 3Q results and guidance that allay many of our concerns. After seemingly hitting bottom in 3Q:12, ALGN has taken concrete steps to revitalize its North American GP dentist segment, stabilize/improve pricing, and build a formidable O-U.S. sales and training operation, all of which are paying dividends. With better overall volume trends, the ClearCorrect ITC victory, and the Realine launch, we see plenty of runway for continued outperformance.”
Align Technology closed on Thursday at $45.93.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in